Company Information
Addex Pharmaceuticals Ltd
Chemin des Aulx 12
1228 Plan-les-Ouates
Suisse
+41 22 884 15 55
http://www.addexpharma.com
- CEO
- Vincent Mutel
- Investor Relations
- Chris Maggos
Addex Pharmaceuticals discovers and develops small molecule therapeutics, called allosteric modulators, which work differently than most marketed drugs. This discovery platform is broadly applicable in multiple and major market indications and can address targets that have not been accessible to classical approaches.
Trading Information
- Sector
- Health Care - 4500
- Regulatory Standard
- International Reporting Standard
- Security Number
- 2985075
- ISIN
- CH0029850754
- Symbol
- ADXN
- Index member
- SPI/SPIEX/SXI® Life Siences
Intermediaries
- Listing Agent
- Niederer Kraft & Frey
- Lead Bank
- Lehman Brothers International (Europe)
- Auditor
- PricewaterhouseCoopers SA
Information on the Issue
| Security Details | |
|---|---|
| First Listing | 22.05.2007 |
| Class of Share | Action nominative |
| Nominal Value | 1.00 CHF |
| Total Shares outstanding (post issue; incl. Greenshore - if any) | 5862492 |
| Allocation Details | |
|---|---|
| Primary Shares | 1875000 |
| Secondary Shares | n/a |
| Primary Greenshoe | 281250 |
| Secondary Greenshoe | n/a |
| Greenshoe Details | |
|---|---|
| Executed | no |
| Ex-date | n/a |
| Executed number of shares | n/a |
| First Trading Day Details | |
|---|---|
| First Trading | 22.05.2007 |
| Price Range | 55.00 - 75.00 CHF |
| Issue Price | 73.00 CHF |
| First Open | 75.00 CHF |
| First Close | 68.00 CHF |
| Transaction size in Mio. (incl. executed Greenshoe) | 136.9 CHF |
| Market Capitalisation in Mio. (based on first closing price) | 399 CHF |
Financial Statement
| Number of Employees | 70 March 2007 |
| Net Revenues in Mio. | 4.8 CHF 31.12.2006 |
| Net Gain in Mio. | n/a |